Characterization of suramin binding sites on the human group IIA secreted phospholipase A(2) by site-directed mutagenesis and molecular dynamics simulation
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
22/10/2013
22/10/2013
2012
|
Resumo |
Suramin is a polysulphonated naphthylurea with inhibitory activity against the human secreted group IIA phospholipase A(2) (hsPLA2GIIA), and we have investigated suramin binding to recombinant hsPLA2GIIA using site-directed mutagenesis and molecular dynamics (MD) simulations. The changes in suramin binding affinity of 13 cationic residue mutants of the hsPLA2GIIA was strongly correlated with alterations in the inhibition of membrane damaging activity of the protein. Suramin binding to hsPLA2GIIA was also studied by MD simulations, which demonstrated that altered intermolecular potential energy of the suramin/mutant complexes was a reliable indicator of affinity change. Although residues in the C-terminal region play a major role in the stabilization of the hsPLA2GIIA/suramin complex, attractive and repulsive hydrophobic and electrostatic interactions with residues throughout the protein together with the adoption of a bent suramin conformation, all contribute to the stability of the complex. Analysis of the h5PLA2GIIA/suramin interactions allows the prediction of the properties of suramin analogues with improved binding and higher affinities which may be candidates for novel phospholipase A(2) inhibitors. (C) 2012 Elsevier Inc. All rights reserved. FAPESP [2009/13902-7, 2002/12746-2] FAPESP CNPq CNPq [152669/2007-8, 504807/2009-9, 304982/2006-7] PRPUSP PRP-USP |
Identificador |
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, NEW YORK, v. 519, n. 1, supl. 4, Part 1, pp. 17-22, 36951, 2012 0003-9861 http://www.producao.usp.br/handle/BDPI/35460 10.1016/j.abb.2012.01.002 |
Idioma(s) |
eng |
Publicador |
ELSEVIER SCIENCE INC NEW YORK |
Relação |
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS |
Direitos |
closedAccess Copyright ELSEVIER SCIENCE INC |
Palavras-Chave | #PLA(2) INHIBITOR #PROTEIN-DRUG BINDING #DRUG DESIGN #MAJOR PHYSIOLOGICAL-ROLE #BACTERIAL-CELL WALL #INHIBITORS #ENZYME #ELECTROSTATICS #PENETRATION #EXPRESSION #ANALOGS #PHASE #BIOCHEMISTRY & MOLECULAR BIOLOGY #BIOPHYSICS |
Tipo |
article original article publishedVersion |